FSCN1 and breast cancer: In this study, we identified the transcriptional landscape enriched in TNBC expressing high fascin, which is associated with shorter survival of FSCN1high patients particularly the TNBC subtype, demonstrating a clinical relevance of our in vitro findings in this breast cancer subtype.